Home / Products / Cancer (Tumor) Cell Lines / LNCaP C4-2
LNCaP C4-2
Datasheet Protocol

LNCaP C4-2

Cat. No. ARC0451
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Prostate

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

LNCaP C4-2 is a cancer cell line of prostate carcinoma, isolated from metastatic; left supraclavicular lymph node.

Recommended Products

MPI Knockout jurkat Polyclonal Cells MPI Knockout jurkat Polyclonal Cells Cat. No. ARG12923 BRAF Knockout HT29 Polyclonal Cells BRAF Knockout HT29 Polyclonal Cells Cat. No. ARG23295 BRK1 Knockout HAP1 Polyclonal Cells BRK1 Knockout HAP1 Polyclonal Cells Cat. No. ARG27414 CAMK1 Knockout Hela Polyclonal Cells CAMK1 Knockout Hela Polyclonal Cells Cat. No. ARG41924 NAT8L Knockout A549 Polyclonal Cells NAT8L Knockout A549 Polyclonal Cells Cat. No. ARG10055 FAM76A Knockout AGS Polyclonal Cells FAM76A Knockout AGS Polyclonal Cells Cat. No. ARG3225
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Prostate
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
50 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Left supraclavicular lymph node
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

PDHA1 Knockout NCI-H1975 Polyclonal Cells

PDHA1 Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16901
 NCOR2 Knockout NCI-H1299 Polyclonal Cells

NCOR2 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17477
 PDIA3 Knockout jurkat Polyclonal Cells

PDIA3 Knockout jurkat Polyclonal Cells

Cat. No. ARG13030
 AKAP7 Knockout 786-O Polyclonal Cells

AKAP7 Knockout 786-O Polyclonal Cells

Cat. No. ARG24867
 IBTK Knockout HGC-27 Polyclonal Cells

IBTK Knockout HGC-27 Polyclonal Cells

Cat. No. ARG29987
 MEIS1 Knockout AGS Polyclonal Cells

MEIS1 Knockout AGS Polyclonal Cells

Cat. No. ARG2581